## CF: CF Industries Holdings, Inc. - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -1.8% below STRENGTH zone (4.0-10.0%); PEG 2.16 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($73.60)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. CF Industries appoints interim CFO amid leadership transition**
- Source: TipRanks | 20260107T113539 | Neutral | Relevance: 100%
- CF Industries Holdings announced a leadership transition, with CFO Gregory Cameron departing on February 15, 2026. Richard Hoker, the company's long-time vice president, corporate controller, and chief accounting officer, has been named interim CFO. The company is actively searching for a permanent successor while navigating this change in its senior financial leadership.

**2. CF Industries CFO Gregory Cameron to depart company in February 2026**
- Source: MSN | 20260107T160925 | Neutral | Relevance: 98%
- CF Industries announced that its Chief Financial Officer, Gregory Cameron, will be departing the company in February 2026. The company will be initiating a search for his successor.

**3. Nutrienâ€™s Stock Tries To Find a Floor as Fertilizer Cycles, China Fears and Rate Cuts Collide**
- Source: AD HOC NEWS | 20260106T000914 | Neutral | Relevance: 64%
- Nutrien's stock is navigating a challenging period marked by a fertilizer downcycle and geopolitical factors, leaving investors divided between value opportunity and value trap. Despite recent stabilization suggesting the worst might be over for fertilizer slump, the stock remains closer to its 52-week low. Wall Street analysts are guardedly optimistic, with most maintaining "Hold" ratings and anticipating a gradual margin recovery contingent on fertilizer price stabilization and improved farmer sentiment.

**4. CHS reports first quarter fiscal 2026 earnings**
- Source: CHS Inc. | 20260107T191204 | Somewhat-Bullish | Relevance: 62%
- CHS Inc. reported a net income of $260.5 million and revenues of $8.9 billion for the first quarter of fiscal year 2026, driven by strong performance in refined fuels and agronomy, despite headwinds in grains. The company's new financial segments provided better insight into its end-to-end supply chain. CHS aims to continue bringing value to owners through efficiency, diversified supply chains, and operational excellence amidst a challenging agricultural market.

**5. Corteva lines up February webcast to detail its Q4 2025 performance**
- Source: Stock Titan | 20260106T130152 | Neutral | Relevance: 62%
- Corteva (NYSE: CTVA) has announced it will release its fourth-quarter 2025 earnings on Tuesday, February 3, 2026, after market close, followed by a live webcast on Wednesday, February 4, 2026, at 9:00 a.m. Eastern Time. The announcement includes key dates and details for investors to access the earnings report and webcast, with a replay available until February 4, 2027. This follows a period of strategic growth for Corteva, including joint ventures, new product launches, and previous guidance raises.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Mizuho | $88 | $92 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Mizuho | main | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (-0.3%)
- Blackrock Inc.: 8.1% (-1.1%)
- State Street Corpora: 5.1% (-0.2%)
- Price (T.Rowe) Assoc: 4.5% (-7.6%)
- Charles Schwab Inves: 4.0% (+8.9%)

### Key Risks

1. Elevated short interest (9.7%): bears positioning against stock.
2. Long-term trend broken: trading 9.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.16 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 22%, margin 20%). Balance sheet: strong liquidity (2.3x). Revenue declining -6% YoY, concerning. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.6B |
| Beta | 0.68 |
| 52W Range | $67.34 - $104.45 |
| Short Interest | 9.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.16 |
| Forward P/E | 10.9 |
| Current P/E | 8.9 |
| YoY Growth | -18.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -0.3% to -1.8% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.8pp (needs >4.0% for momentum thesis). Underperforming sector by 3.5pp, stock-specific weakness. Below SMA200 (0.91x), long-term trend not supportive. RSI neutral at 45. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.78% (CS: 32) | Neutral |
| RSI_14 | 44.6 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 0.992x | Below |
| vs SMA50 | 0.967x | Below |
| vs SMA200 | 0.910x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $77.48
- **Stop Loss:** $73.60 (5.0% risk)
- **Target:** $81.36 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 193
- **Position Value:** $14,953.64
- **Portfolio %:** 14.95%
- **Risk Dollars:** $750.00
- **Risk Per Trade:** 0.75%
- **Modifiers:** L1 100% | L2 75% | Combined 0.75x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-02-18 (Est: $2.34)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.07 | $2.19 | +5.6% |
| 2025Q2 | $2.48 | $2.37 | -4.5% |
| 2025Q1 | $1.51 | $1.85 | +22.9% |
| 2024Q4 | $1.52 | $1.89 | +24.5% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_20*